KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/12/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization212,302 mln
Float12.90 mln
Earnings Date08/07/2025
EPS
104
Stretched
P / E
101
Highly speculative
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.36
Borderline
Relative Strength
12
/ 100
Significantly lagging
Debt / Equity
1.27
Elevated leverage
Business Description
Founded in 1984 and based in Seoul, South Korea, Dae Hwa Pharmaceutical Co. Ltd. develops and distributes a broad range of medicines covering areas such as cancer treatment, diabetes, heart health, mental health, skin conditions, and digestive care, among many others. The company also produces vitamins, nutritional supplements, and cosmetic products, along with active pharmaceutical ingredients and skin-absorbed drug delivery systems. Beyond its home market, Dae Hwa exports to around 22 countries across Asia, South America, the Middle East, and Africa.
